Literature DB >> 11762683

A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992.

J Thumboo1, K Uramoto, W M O'Fallon, K Y Fong, M L Boey, P H Feng, S T Thio, S E Gabriel, H H Chng, H S Howe, E T Koh, W H Koh, K H Leong, K P Leong.   

Abstract

OBJECTIVE: To examine the relationship between ethnicity and major organ involvement at and after diagnosis in community-based cohorts of Caucasian and Chinese systemic lupus erythematosus (SLE) patients resident in Rochester, Minnesota, and Singapore, respectively.
METHODS: Clinical manifestations at and after diagnosis were compared in Caucasian and Chinese SLE patients. The association between ethnicity and disease manifestations at and after diagnosis was determined using logistic regression and Cox proportional hazards models, respectively, adjusting for the influence of demographic, socioeconomic, disease-related, and therapy-related factors.
RESULTS: At diagnosis, Caucasian SLE patients were 3 times more likely than Chinese SLE patients to have serositis (odds ratio [OR] 3.11, 95% confidence interval [CI] 1.01-9.71), nearly 7 times more likely to have a hematologic disorder (OR 6.95, 95% CI 2.20-21.97), and far less likely to have a malar rash (OR 0.19, 95% CI 0.07-0.54) or positive antinuclear antibodies (OR 0.11, 95% CI 0.03-0.52). Ethnicity was not associated with the prevalence of proteinuria or central nervous system (CSN) and other major organ involvement at diagnosis. After diagnosis, there was a trend toward less development of proteinuria and other major organ involvement in Caucasians (relative risk [RR] 0.47, 95% CI 0.19-1.15, and RR 0.22, 95% CI 0.05-1.04, respectively).
CONCLUSION: Chinese SLE patients are far less likely to have serositis or a hematologic disorder at diagnosis and may be more likely to develop proteinuria or CNS or other major organ involvement over the course of the disease, compared with Caucasian SLE patients. This may contribute to the increased mortality seen in Chinese SLE patients.

Entities:  

Mesh:

Year:  2001        PMID: 11762683     DOI: 10.1002/1529-0131(200112)45:6<494::aid-art374>3.0.co;2-m

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

Review 1.  Ethnic disparities in patients with systemic lupus erythematosus.

Authors:  América G Uribe; Graciela S Alarcón
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

2.  Spectrum of ankylosing spondylitis in Portugal. Development of BASDAI, BASFI, BASMI and mSASSS reference centile charts.

Authors:  Fernando M Pimentel-Santos; Ana Filipa Mourão; Célia Ribeiro; José Costa; Helena Santos; Anabela Barcelos; Patricia Pinto; Fátima Godinho; Margarida Cruz; Elsa Vieira-Sousa; Rui André Santos; Sara Rabiais; Jorge Félix; João Eurico Fonseca; Henrique Guedes-Pinto; Matthew A Brown; Jaime C Branco
Journal:  Clin Rheumatol       Date:  2011-10-19       Impact factor: 2.980

Review 3.  The BAFF/APRIL system in SLE pathogenesis.

Authors:  Fabien B Vincent; Eric F Morand; Pascal Schneider; Fabienne Mackay
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

Review 4.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

5.  Associations of B cell-activating factor (BAFF) and anti-BAFF autoantibodies with disease activity in multi-ethnic Asian systemic lupus erythematosus patients in Singapore.

Authors:  H S Howe; B Y H Thong; K O Kong; H H Chng; T Y Lian; F L Chia; K S S Tay; T C Lau; W G Law; E T Koh; B P Leung
Journal:  Clin Exp Immunol       Date:  2017-05-02       Impact factor: 4.330

Review 6.  Neuropsychiatric involvement in systemic lupus erythematosus.

Authors:  David Hermosillo-Romo; Robin L Brey
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

7.  Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Jennifer L Medlin; Karen E Hansen; Sara S McCoy; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2018-01-31       Impact factor: 5.532

8.  Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.

Authors:  So-Yeon Park; Young Bin Joo; Jeeseon Shim; Yoon-Kyoung Sung; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2015-08-09       Impact factor: 2.631

9.  Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study.

Authors:  M Scolnik; J Marin; S M Valeiras; M F Marchese; A S Talani; N L Avellaneda; A Etchepare; P Etchepare; M S Plou; E R Soriano
Journal:  Lupus Sci Med       Date:  2014-06-05

10.  Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus.

Authors:  K L Connelly; R Kandane-Rathnayake; A Hoi; Mandana Nikpour; E F Morand
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.